Kathryn E. Wengel - 13 Feb 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief TO and Risk Officer
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
13 Feb 2025
Net transactions value
-$516,081
Form type
4
Filing time
18 Feb 2025, 21:16:54 UTC
Previous filing
13 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +651 +0.73% $0.000000 89,603 13 Feb 2025 Direct F1
transaction JNJ Common Stock Tax liability $34,623 -223 -0.25% $155.26 89,380 14 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +1,530 +1.7% $0.000000 90,910 14 Feb 2025 Direct F3
transaction JNJ Common Stock Tax liability $75,221 -480 -0.53% $156.71 90,430 14 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +607 +0.67% $0.000000 91,037 15 Feb 2025 Direct F4
transaction JNJ Common Stock Tax liability $31,230 -200 -0.22% $156.15 90,837 18 Feb 2025 Direct F2
transaction JNJ Common Stock Options Exercise $0 +5,837 +6.4% $0.000000 96,674 14 Feb 2025 Direct F5
transaction JNJ Common Stock Tax liability $375,007 -2,393 -2.5% $156.71 94,281 14 Feb 2025 Direct F6
holding JNJ Common Stock 281 13 Feb 2025 By ESOP F7
holding JNJ Common Stock 75 13 Feb 2025 By 401k F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -651 -50% $0.000000 651 13 Feb 2025 Common Stock 651 Direct F1, F9
transaction JNJ Restricted Share Units Options Exercise $0 -1,530 -100% $0.000000 0 14 Feb 2025 Common Stock 1,530 Direct F3
transaction JNJ Restricted Share Units Options Exercise $0 -607 -33% $0.000000 1,212 15 Feb 2025 Common Stock 607 Direct F4, F9
transaction JNJ Performance Share Units Options Exercise $0 -5,837 -100% $0.000000 0 14 Feb 2025 Common Stock 5,837 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of RSUs.
F3 Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting.
F4 Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
F5 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. The PSUs convert into shares of Common Stock upon vesting.
F6 Shares withheld for payment of taxes upon vesting of PSUs.
F7 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F8 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F9 Each RSU represents a contingent right to receive one share of Company Common Stock.